The Bronx, NYNCT06513026Now EnrollingIRB Ready

Lactose Intolerance Clinical Trial in The Bronx, NY

Access cutting-edge lactose intolerance treatment through this clinical trial at a research site in The Bronx. Study-provided care at no cost to qualified participants.

Sponsored by Albert Einstein College of Medicine

Quick Self-Assessment

See if you qualify for this The Bronx location

Preparing your pre-screening questions…

Expert Care in The Bronx

Access lactose intolerance specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lactose intolerance treatment provided free

Apply for This The Bronx Location

Check if you qualify for this lactose intolerance clinical trial in The Bronx, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to The Bronx

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit The Bronx site if eligible
  4. 4Begin participation

About This Lactose Intolerance Study in The Bronx

Individuals with lactase non-persistence (LNP; determined by a functional variant in the LCT gene \[rs4988235, GG genotype\]) are susceptible to lactose intolerance in adulthood due to deficiency of lactase, the enzyme which digests milk lactose sugars. However, many LNP individuals still drink ≥1 cup of milk daily. Recent analysis in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) found that consumption of 1 serving (cup) of milk/day was associated with \~30% lower risk of type 2 diabetes among LNP individuals, but not among individuals with lactase persistence (LP). This beneficial effect might be partially explained by favorable alterations in gut microbiota and related metabolites associated with higher milk consumption among LNP individuals. Based on these observational study findings, the investigator team proposes to conduct a randomized, controlled trial of lactose-containing vs. lactose-free milk in LNP individuals with pre-diabetes, to comprehensively investigate the effects of milk intake on the gut microbiome and glycemic outcomes.

Sponsor: Albert Einstein College of Medicine

Who Can Participate

Inclusion Criteria

LNP genotype (LCT gene rs4988235, GG genotype)
History of pre-diabetes, defined as fasting blood glucose 100-125 mg/dL and/or hemoglobin A1c (HbA1c) 5.7-6.4% and have not been diagnosed with diabetes nor take diabetes medication (pre-diabetes determined at most recent study visit \[for HCHS/SOL participant\] or most recent medical chart or self-report \[for other participant\])
Drink ≤1 cup milk/day
Basic computer or smartphone skills
Can speak and read English fluently

Exclusion Criteria

Diabetes diagnosis
Taking anti-diabetes medication
Cancer, cardiovascular disease (CVD), or life-threatening illness
Known milk allergy
Has severe GI symptoms after drinking milk
History of GI surgery
Had a double mastectomy
More than 1 alcoholic beverage/day
Pregnant or breastfeeding
Colonoscopy in last 2 weeks
Antibiotics in last 3 months
Taking probiotics or fiber supplements (if taking, must be able to stop taking during study)
Taking laxatives, stool softeners, anti-diarrheal (if taking, must be able to stop taking during study)
Taking lactase pills (if taking, must be able to stop taking)
Participating in extreme dieting program
Planning extended travel that would prevent participation in study
Taking medication that must be taken separate from calcium or dairy products

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in The Bronx?

Yes, this clinical trial (NCT06513026) has an active research site in The Bronx, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lactose Intolerance Treatment Options in The Bronx, NY

If you're searching for lactose intolerance treatment options in The Bronx, NY, this clinical trial (NCT06513026) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our The Bronx research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lactose intolerance specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lactose intolerance clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in The Bronx, NY

See all rheumatoid arthritis clinical trials recruiting in The Bronx — not just this study.

Browse Rheumatoid Arthritis Trials in The Bronx →

Browse More Trials by Condition

Ready to Join in The Bronx?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · The Bronx, NY